Author Correction: PHF14: an Innate Inhibitor Against the Progression of Renal Fibrosis Following Folic Acid-Induced Kidney Injury

Bo Yang,Sixiu Chen,Ming Wu,Lin Zhang,Mengna Ruan,Xujiao Chen,Zhengjun Chen,Changlin Mei,Zhiguo Mao

DOI: https://doi.org/10.1038/s41598-020-62765-7

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

What problem does this paper attempt to address?

Phf14: An Innate Inhibitor Against The Progression Of Renal Fibrosis Following Folic Acid-Induced Kidney Injury (Vol 7, 39888, 2017)

Bo Yang,Sixiu Chen,Ming Wu,Lin Zhang,Mengna Ruan,Xujiao Chen,Zhengjun Chen,Changlin Mei,Zhiguo Mao

DOI: https://doi.org/10.1038/s41598-020-62765-7

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
PHF14: an Innate Inhibitor Against the Progression of Renal Fibrosis Following Folic Acid-Induced Kidney Injury

Bo Yang,Sixiu Chen,Ming Wu,Lin Zhang,Mengna Ruan,Xujiao Chen,Zhengjun Chen,Changlin Mei,Zhiguo Mao

DOI: https://doi.org/10.1038/srep39888

IF: 4.6

2017-01-01

Scientific Reports

Abstract:PHF14 is a newly identified regulator of mesenchyme growth in embryonic tissues. Previous studies have shown that phf14-null mutants die just after birth due to interstitial tissue hyperplasia in major organs, including the kidneys. The aim of this study was to investigate PHF14 function in renal fibrosis. By studying the chronic kidney injury mouse model, we found that PHF14 was upregulated in fibrotic kidneys after renal insults induced by folic acid administration. Compared with wild-type mice, PHF14-null mice showed more severe renal fibrosis after pro-fibrotic stimuli. Moreover, PHF14 in rat renal fibroblasts was upregulated by transforming growth factor-β (TGF-β) stimulation; while this upregulation was inhibited when smad3 phosphorylation was blocked. A chromatin immunoprecipitation (ChIP) assay further indicated that phospho-smad3 (p-smad3) acted as a transcription factor to enhance PHF14 expression. A lack of PHF14 expression enhanced collagen I and α-smooth muscle actin (α-SMA) synthesis induced by TGF-β in vitro. PHF14 was involved in inhibition of platelet-derived growth factor (PDGF) signaling overactivation by selectively repressing PDGF receptor-α (PDGFR-α) transcription. In summary, PHF14 expression was upregulated in fibrotic models in vivo and in vitro, and the TGF-β/smad3/PHF14 pathway acted as a self-limiting mechanism in the TGF-β-dominated renal pro-fibrotic process by suppressing PDGFR-α expression.
Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury

Jiajia Li,Yupeng Jiang,Qin Dai,Yue Yu,Xin Lv,Yan Zhang,Xiaohua Liao,Liyun Ao,Gaoyun Hu,Jie Meng,Zhangzhe Peng,Lijian Tao,Yanyun Xie

DOI: https://doi.org/10.3389/fphar.2023.1188615

IF: 5.6

2023-04-06

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.1043945.].

pharmacology & pharmacy
Corrigendum: the Role of Krüppel-like Factor 4 in Renal Fibrosis

Ben Ke,Afei Zhang,Xianfeng Wu,Xiangdong Fang

DOI: https://doi.org/10.3389/fphys.2016.00059

IF: 4

2016-01-01

Frontiers in Physiology

Abstract:[This corrects the article on p. 327 in vol. 6, PMID: 26617530.].
Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway

Yu-Li Shen,Yi-ping Jiang,Xiao-Qin Li,Su-Juan Wang,Ming-Hua Ma,Chun-Yan Zhang,Jian-Yong Zhu,Khalid Rahman,Li-Jun Zhang,Xin Luan,Hong Zhang

DOI: https://doi.org/10.3389/fphar.2021.789192

IF: 5.6

2021-11-18

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2019.01596.].

pharmacology & pharmacy
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Author Correction: MC1R is Dispensable for the Proteinuria Reducing and Glomerular Protective Effect of Melanocortin Therapy

Yingjin Qiao,Anna-Lena Berg,Pei Wang,Yan Ge,Songxia Quan,Sijie Zhou,Hai Wang,Zhangsuo Liu,Rujun Gong

DOI: https://doi.org/10.1038/s41598-020-72744-7

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Corrigendum: Fucoidan ameliorates renal injury-related calcium-phosphorus metabolic disorder and bone abnormality in the CKD-MBD model rats by targeting FGF23-Klotho signaling axis

Bu-Hui Liu,Fee-Lan Chong,Can-Can Yuan,Ying-Lu Liu,Hai-Ming Yang,Wen-Wen Wang,Qi-Jun Fang,Wei Wu,Mei-Zi Wang,Yue Tu,Zi-Yue Wan,Yi-Gang Wan,Guo-Wen Wu

DOI: https://doi.org/10.3389/fphar.2024.1446609

2024-07-23

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.586725.].
Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study

Tang-Hsiu Huang,Chin-Wei Kuo,Chian-Wei Chen,Yau-Lin Tseng,Chao-Liang Wu,Sheng-Hsiang Lin

DOI: https://doi.org/10.1186/s12890-021-01559-7

IF: 3.1

2021-06-08

BMC Pulmonary Medicine

Abstract:An amendment to this paper has been published and can be accessed via the original article.

respiratory system
Corrigendum: Matrix Metalloproteinase-7 and Kidney Fibrosis

Ben Ke,Chuqiao Fan,Liping Yang,Xiangdong Fang

DOI: https://doi.org/10.3389/fphys.2017.00192

IF: 4

2017-01-01

Frontiers in Physiology

Abstract:[This corrects the article on p. 21 in vol. 8, PMID: 28239354.].
Correction: Fucoidans from Cucumaria frondosa ameliorate renal interstitial fibrosis via inhibition of the PI3K/Akt/NF-κB signaling pathway

Zhuoyue Song,Mengru Zhu,Jun Wu,Tian Yu,Yao Chen,Xianying Ye,Shijie Li,Nenggui Xu

DOI: https://doi.org/10.1039/d2fo90016e

2022-01-01

Abstract:Correction for ‘Fucoidans from Cucumaria frondosa ameliorate renal interstitial fibrosis via inhibition of the PI3K/Akt/NF-κB signaling pathway’ by Zhuoyue Song et al. , Food Funct. , 2022, 13 , 1168–1179, DOI: 10.1039/D1FO03067A.

biochemistry & molecular biology,food science & technology
Author Correction to ‘FGF4 Protects the Liver from Immune-Mediated Injury by Activating CaMKKβ-PINK1 Signal Pathway to Inhibit Hepatocellular Apoptosis’ [acta Pharmaceutica Sinica B 14(2024)1605-1623]

Zhifeng Huang,Tongtong Pan,Liang Xu,Lu Shi,Xiong Ma,Liya Zhou,Luyao Wang,Jiaojiao Wang,Guoqing Zhu,Dazhi Chen,Lingtao Song,Xiaomin Pan,Xiaodong Wang,Xiaokun Li,Yongde Luo,Yongping Chen

DOI: https://doi.org/10.1016/j.apsb.2024.04.008

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2023.12.012.].
Corrigendum: HBSP improves kidney ischemia-reperfusion injury and promotes repair in properdin deficient mice via enhancing phagocytosis of tubular epithelial cells

Yuanyuan Wu,Lili Huang,Wenli Sai,Fei Chen,Yu Liu,Cheng Han,Joanna M. Barker,Zinah D. Zwaini,Mark P. Lowe,Nigel J. Brunskill,Bin Yang

DOI: https://doi.org/10.3389/fimmu.2023.1242436

IF: 7.3

2023-06-29

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1183768.].

immunology
Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum

Haoran Liu,Xiaoqi Yang,Kun Tang,Tao Ye,Chen Duan,Peng Lv,Libin Yan,Xiaoliang Wu,Zhiqiang Chen,Jianhe Liu,Yaoliang Deng,Guohua Zeng,Jinchun Xing,Zhangqun Ye,Hua Xu

DOI: https://doi.org/10.7150/thno.68830

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.44054.].

medicine, research & experimental
Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation

Qiang Wang,Yuemei Xi,Binyang Chen,Hairong Zhao,Wei Yu,De Xie,Weidong Liu,Furong He,Chenxi Xu,Jidong Cheng

DOI: https://doi.org/10.3389/fphar.2022.1022539

IF: 5.6

2022-11-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.907133.].

pharmacology & pharmacy
Author Correction: P66shc: A Novel Biomarker of Tubular Oxidative Injury in Patients with Diabetic Nephropathy.

Xiaoxuan Xu,Xuejing Zhu,Mingming Ma,Yachun Han,Chun Hu,Shuguang Yuan,Yuan Yang,Li Xiao,Fuyou Liu,Yashpal S Kanwar,Lin Sun

DOI: https://doi.org/10.1038/s41598-020-62787-1

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Author Correction: P66shc: A Novel Biomarker of Tubular Oxidative Injury in Patients with Diabetic Nephropathy

Xiaoxuan Xu,Xuejing Zhu,Mingming Ma,Yachun Han,Chun Hu,Shuguang Yuan,Yang Yuan,Li Xiao,Fuyou Liu,Yashpal S. Kanwar,Lin Sun

DOI: https://doi.org/10.1038/s41598-020-62787-1

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Correction: Corrigendum: Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury

Huafeng Wang,Huan Zhang,Zimu Zhang,Biao Huang,Xixi Cheng,Dan Wang,Zha la Gahu,Zhenyi Xue,Yurong Da,Daiqing Li,Zhi Yao,Fei Gao,Aimin Xu,Rongxin Zhang

DOI: https://doi.org/10.1038/srep26729

IF: 4.6

2016-01-01

Scientific Reports

Abstract:Scientific Reports 6: Article number: 19445; published online: 18 January 2016; updated: 31 May 2016 This Article contains typographical errors in the Methods section under subheading ‘Chemicals and Animals’, “Thioacetamide (TAA) (Sigma-Aldrich, Switzerland), ADP355 (H-Asn-Ile-Pro-Nva-Leu-Tyr-Ser-Phe-Ala- DSer-NH2) and scramble (H-Pro-Ile-Asn-Tyr-Ala-Nva-Ser-Phe-Leu-Ser-NH2) (Lysine Bio-system, China) were all dissolved in PBS”.
Corrigendum: Transcriptional progressive patterns from mild to severe renal ischemia/reperfusion-induced kidney injury in mice

Dong Lai,Lei Wang,Jia-Rui Li,Chen Chen,Wen-Lei Zhao,Qing Yuan,Xin Ma,Xu Zhang

DOI: https://doi.org/10.3389/fgene.2022.1011276

IF: 3.7

2022-09-13

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.874189.].

genetics & heredity
Corrigendum: Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway

Xiaowan Wang,Jinchu Liu,Ruimin Tian,Bidan Zheng,Chuang Li,Lihua Huang,Zhisheng Lu,Jing Zhang,Wei Mao,Bo Liu,Kun Bao,Peng Xu

DOI: https://doi.org/10.3389/fphar.2022.905693

IF: 5.6

2022-04-27

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.727874.].

pharmacology & pharmacy

Author Correction: PHF14: an Innate Inhibitor Against the Progression of Renal Fibrosis Following Folic Acid-Induced Kidney Injury

Phf14: An Innate Inhibitor Against The Progression Of Renal Fibrosis Following Folic Acid-Induced Kidney Injury (Vol 7, 39888, 2017)

PHF14: an Innate Inhibitor Against the Progression of Renal Fibrosis Following Folic Acid-Induced Kidney Injury

Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury

Corrigendum: the Role of Krüppel-like Factor 4 in Renal Fibrosis

Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Author Correction: MC1R is Dispensable for the Proteinuria Reducing and Glomerular Protective Effect of Melanocortin Therapy

Corrigendum: Fucoidan ameliorates renal injury-related calcium-phosphorus metabolic disorder and bone abnormality in the CKD-MBD model rats by targeting FGF23-Klotho signaling axis

Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study

Corrigendum: Matrix Metalloproteinase-7 and Kidney Fibrosis

Correction: Fucoidans from Cucumaria frondosa ameliorate renal interstitial fibrosis via inhibition of the PI3K/Akt/NF-κB signaling pathway

Author Correction to ‘FGF4 Protects the Liver from Immune-Mediated Injury by Activating CaMKKβ-PINK1 Signal Pathway to Inhibit Hepatocellular Apoptosis’ [acta Pharmaceutica Sinica B 14(2024)1605-1623]

Corrigendum: HBSP improves kidney ischemia-reperfusion injury and promotes repair in properdin deficient mice via enhancing phagocytosis of tubular epithelial cells

Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum

Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation

Author Correction: P66shc: A Novel Biomarker of Tubular Oxidative Injury in Patients with Diabetic Nephropathy.

Author Correction: P66shc: A Novel Biomarker of Tubular Oxidative Injury in Patients with Diabetic Nephropathy

Correction: Corrigendum: Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury

Corrigendum: Transcriptional progressive patterns from mild to severe renal ischemia/reperfusion-induced kidney injury in mice

Corrigendum: Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]